Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
Authors:
- Bernardino ClavoBernardino Clavo
- Gregorio Martínez-SánchezGregorio Martínez-Sánchez
- Francisco Rodríguez-EsparragónFrancisco Rodríguez-Esparragón
- Delvys Rodríguez-AbreuDRDelvys Rodríguez-Abreu
- Saray GalvánSGSaray Galván
- David Aguiar-BujandaDADavid Aguiar-Bujanda
- Juan A. Díaz-GarridoJDJuan A. Díaz-Garrido
- Silvia CañasSCSilvia Cañas
- Laura B. Torres-MataLTLaura B. Torres-Mata
- Himar FabeloHimar Fabelo
- Teresa TéllezTTTeresa Téllez
- Norberto Santana-RodríguezNSNorberto Santana-Rodríguez
Open Access
- 10 March 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2802
Abstract
(1) Background: Chemotherapy-induced peripheral neuropathy (CIPN) decreases the quality of life of patients and can lead to a dose reduction and/or the interruption of chemotherapy treatment, limiting its effectiveness. Potential pathophysiological mechanisms involved in the pathogenesis of CIPN include chronic oxidative stress and subsequent increase in free radicals and proinflammatory cytokines. Approaches for the treatment of CIPN are highly limited in their number and efficacy, although several antioxidant-based therapies have been tried. On the other hand, ozone therapy can induce an adaptive antioxidant and anti-inflammatory response, which could be potentially useful in the management of CIPN. (2) Methods: The aims of this works are: (a) to summarize the potential mechanisms that could induce CIPN by the most relevant drugs (platinum, taxanes, vinca alkaloids, and bortezomib), with particular focus on the role of oxidative stress; (b) to summarize the current situation of prophylactic and treatment approaches; (c) to describe the action mechanisms of ozone therapy to modify oxidative stress and inflammation with its potential repercussions for CIPN; (d) to describe related experimental and clinical reports with ozone therapy in chemo-induced neurologic symptoms and CIPN; and (e) to show the main details about an ongoing focused clinical trial. (3) Results: A wide background relating to the mechanisms of action and a small number of experimental and clinical reports suggest that ozone therapy could be useful to prevent or improve CIPN. (4) Conclusions: Currently, there are no clinically relevant approaches for the prevention and treatment of stablished CIPN. The potential role of ozone therapy in this syndrome merits further research. Randomized controlled trials are ongoing.Keywords
Funding Information
- Instituto de Salud Carlos III (PI 19/00458)
- Fundación DISA (016/2019)
- Fundación Española del Dolor (BF1-19-13)
- Colegio Oficial de Médicos de Las Palmas (I42/20)
This publication has 103 references indexed in Scilit:
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathyRedox Biology, 2013
- Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in miceInhalation Toxicology, 2011
- Ozone acting on human blood yields a hormetic dose-response relationshipJournal of Translational Medicine, 2011
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illnessProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Spectral imaging of the retinaEye, 2011
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialThe Lancet, 2010
- Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyJournal of Clinical Oncology, 2010
- Role of Hydrogen Peroxide in NF-κB Activation: From Inducer to ModulatorAntioxidants & Redox Signaling, 2009
- Effect of Aqueous Ozone on the NF-κB SystemJournal of Dental Research, 2007